knowledge -WSS

knowledge

author：fashion 2025-09-27 21:27:01 - browse：949

Adobe

The Food and Drug Administration is expected to approve Merck’s drug to treat a rare lung disorder called pulmonary arterial hypertension on Tuesday, making available a novel treatment for a deadly condition that’s long been challenging to treat.

In a large trial published last year, the drug, called sotatercept, exceeded expectations in significantly increasing the distance that patients could walk and cutting the risk that their condition would worsen, that they would die, and that they would need new treatments.

Pulmonary arterial hypertension, or PAH, is estimated to occur in 15 to 50 per million people, mostly in women. It’s characterized by a proliferation of cells in the blood vessels that connect the right side of heart to the lungs, making it harder for blood to pass through and leading the heart to have to work harder to pump blood into the lungs. The disease, which causes difficulty breathing, fatigue and dizziness, has a high mortality rate, with one study finding that one-fifth of patients died at around three years after diagnosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

knowledge

WSS

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

There's no autism epidemic. It's an autism diagnosis epidemic

Oprah kicked off a national conversation on obesity. Let's have it

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

Supreme Court mifepristone arguments center on docs' right to sue

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

leisure time

knowledge

entertainment

In Memoriam: Notable people who died in 2023

Roche subsidiary Foundation Medicine opens new headquarters

How one medical school became remarkably diverse

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

At least 13 dead in Texas as scorching temps continue

Judge denies Trump's request for new trial in E. Jean Carroll case

Medical records are filled with copy

Steward Health Care has deal to sell doctor network to UnitedHealth

Continuity nursing helped my family in our darkest PICU moments

The Readout: Lenmeldy, GLP

knowledge

Hormonal contraceptives don’t actually treat endometriosis

Washington mulls new rules to avert another Change Healthcare

Caribou posts encouraging results on off

There's no autism epidemic. It's an autism diagnosis epidemic

A new ‘biological computer' targets cancer while sparing healthy cells

Abortion pill Supreme Court ruling could impact entire drug industry

focus

hotspot

knowledge

entertainment